Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
Our NxStage® System One™ with NxView™ empowers nurses to focus on patients instead of tech. The simple, versatile system delivers renal replacement therapy throughout a patient's stay in the ICU.
With the Novalung® extracorporeal support device, we’ve taken a meaningful leap forward in the treatment of critical heart and lung conditions. This portable therapy solution is designed for use in various clinical care settings, including the ICU, to provide patients with acute respiratory or cardiopulmonary failure the time and support they need to heal. To learn more about Novalung and its recent FDA clearance, read this informative news release.
© 2020, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Novalung, NxStage, NxView, System One, multiFiltrate, multiBic, and multiPlus are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. P/N 103878-01 Rev B 05/2020